AUTL
Autolus Therapeutics
AUTL
AUTL
99 hedge funds and large institutions have $648M invested in Autolus Therapeutics in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 30 increasing their positions, 37 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
19% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 37
63% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 16
76% less call options, than puts
Call options by funds: $20K | Put options by funds: $83K
Holders
99
Holding in Top 10
2
Calls
$20K
Puts
$83K
Top Buyers
| 1 | +$23M | |
| 2 | +$19.9M | |
| 3 | +$2.76M | |
| 4 |
AC
Armistice Capital
New York
|
+$2.26M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$1.5M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$4.1M | |
| 3 | -$3.95M | |
| 4 |
Renaissance Technologies
New York
|
-$3.25M |
| 5 |
EAM
Exome Asset Management
New York
|
-$2.92M |